Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Current Liabilities -----

What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Current Liabilities ratio of NATH BIOGENES (INDIA) is - based on Mar2025 Consolidated results.
Year Current Liabilities
Mar2025-
Mar2024-
Mar2023-
Mar2022-
Mar2013-

How is Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Current Liabilities % Change
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2013 - -

Compare Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹317.0 Cr -1% -4.8% -12.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,770.3 Cr -5.4% -4.2% -31% Stock Analytics
KAVERI SEED COMPANY ₹5,503.0 Cr 7.1% 1.1% 15.6% Stock Analytics
VENKYS (INDIA) ₹1,912.2 Cr -0.2% -7.4% -23.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,229.5 Cr -4.1% -3.1% -27.1% Stock Analytics
INDO US BIOTECH ₹258.5 Cr -0.8% -0.3% -48.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-1%

-4.8%

-12.8%

SENSEX

1.6%

2.7%

6.3%


You may also like the below Video Courses